Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-11 @ 12:56 AM
Study NCT ID:
NCT03082833
Status:
TERMINATED
Last Update Posted:
2019-05-20
First Post:
2017-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-16
First Submit QC Date:
None
Study First Post Date:
2017-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-17
Last Update Post Date:
2019-05-20
Last Update Post Date Type:
ACTUAL